Table 3.
Summary of studies relevant to the risk of cardiovascular disease in renal transplant recipients
Area of study | Types of studies | Reference number |
---|---|---|
Traditional cardiovascular risk factors | ||
Hypertension | Observational–prospective Observational–cross-sectional Observational–retrospective |
20 19 18, 22, 23 |
Diabetes mellitus | Registry data Observational–retrospective Consensus meeting |
27 28, 29, 30 32 |
Dyslipidaemia | Observational–retrospective Double-blind RCT Post-hoc analysis of RCT |
15, 28 12, 39 37 |
Smoking | Observational–retrospective Post-hoc analysis of RCT |
40 41 |
Obesity | Systematic review Observational–prospective Observational–retrospective Registry study |
44 46 45, 47, 48 43 |
Non-traditional cardiovascular risk factors | ||
Renal impairment | Nested case-control within RCT Post-hoc analysis of RCT |
49 50 |
Proteinuria | Systematic review Meta-analysis Observational–retrospective |
54 55 53, 56 |
Left ventricular hypertrophy | Double-blind RCT Observational–prospective Observational–retrospective |
62 61 57 |
Anaemia | Systematic review Observational–retrospective |
54 57 |
Acute rejection | Observational–retrospective | 15, 64 |
Immunosuppression-related cardiovascular risk | ||
Belatacept use | Systematic review Observational–retrospective |
66 65 |
Cardiovascular risk prediction | ||
Renal transplant recipients | Systematic review Observational–prospective Observational–retrospective Validation on RCT data |
71 69 64, 67, 68, 70 72, 73 |
Biomarkers of cardiovascular disease | Post-hoc analysis of RCT Meta-analysis Observational–prospective |
80 75, 76, 77 78, 79 |